TY - UNPB
T1 - Eye Movement Desensitization and Reprocessing (EMDR) Treatment in the Medical Setting
T2 - A Systematic Review
AU - Driessen, Helen Pieternel Antonie
AU - Morsink, Sid
AU - Busschbach, Jan
AU - Hoogendijk, Witte J.G.
AU - Kranenburg, Leonieke W.
N1 - Acknowledgments
The research was supported by a grant from the Foundation Roparun.
PY - 2023/7/3
Y1 - 2023/7/3
N2 - BackgroundThis systematic literature review aims to evaluate the use and effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy in adult patients treated in the medical setting.MethodsWe performed a systematic literature search of MEDLINE, Web of Science, PsycINFO, and the Cochrane Central Register of Controlled Trials, following the PRISMA guidelines. Studies were included if the effectiveness of EMDR was assessed in adult patients treated in a medical setting. Excluded were patients exclusively suffering from a mental health disorder, without somatic comorbidity. A risk of bias analysis was performed. This review was specified in advance and registered on PROSPERO (CRD42022325238).Findings89 studies are included and categorized in 14 medical domains: pain, oncology, neurology, obstetrics, otorhinolaryngology, rheumatology, cardiology, gynecology, dentistry, dermatology, pulmonary medicine, internal medicine, nephrology, and intensive care unit. In addition, three studies focusing on persistent physical complaints were included. Most frequently used outcomes were anxiety, depression, PTSD symptoms, and pain. These outcomes were assessed by study-specific and validated outcome measures. EMDR was found to be adequate in reducing symptoms in nearly all studies included (87/89). Only two studies, within the field of gynecology, reported either no beneficial effects or that the beneficial effects did not remain over time. Notably, the occurrence of adverse events was rarely mentioned.InterpretationEMDR seems to have a beneficial effect on improving psychological and physical symptoms, including anxiety, PTSD, and pain, in adults treated in a medical setting. Most evidence exists for its application in the fields of oncology, pain, and neurology. The average treatment duration was relatively short, which further improves applicability in the medical setting.
AB - BackgroundThis systematic literature review aims to evaluate the use and effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy in adult patients treated in the medical setting.MethodsWe performed a systematic literature search of MEDLINE, Web of Science, PsycINFO, and the Cochrane Central Register of Controlled Trials, following the PRISMA guidelines. Studies were included if the effectiveness of EMDR was assessed in adult patients treated in a medical setting. Excluded were patients exclusively suffering from a mental health disorder, without somatic comorbidity. A risk of bias analysis was performed. This review was specified in advance and registered on PROSPERO (CRD42022325238).Findings89 studies are included and categorized in 14 medical domains: pain, oncology, neurology, obstetrics, otorhinolaryngology, rheumatology, cardiology, gynecology, dentistry, dermatology, pulmonary medicine, internal medicine, nephrology, and intensive care unit. In addition, three studies focusing on persistent physical complaints were included. Most frequently used outcomes were anxiety, depression, PTSD symptoms, and pain. These outcomes were assessed by study-specific and validated outcome measures. EMDR was found to be adequate in reducing symptoms in nearly all studies included (87/89). Only two studies, within the field of gynecology, reported either no beneficial effects or that the beneficial effects did not remain over time. Notably, the occurrence of adverse events was rarely mentioned.InterpretationEMDR seems to have a beneficial effect on improving psychological and physical symptoms, including anxiety, PTSD, and pain, in adults treated in a medical setting. Most evidence exists for its application in the fields of oncology, pain, and neurology. The average treatment duration was relatively short, which further improves applicability in the medical setting.
U2 - 10.2139/ssrn.4495140
DO - 10.2139/ssrn.4495140
M3 - Preprint
T3 - THELANCET-D-23-03420
BT - Eye Movement Desensitization and Reprocessing (EMDR) Treatment in the Medical Setting
ER -
